Logo
x

Search category

Subscribe Now

60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals’ Tafenoquine Gains the US FDA’s Orphan Drug Designation to Treat Acute Babesiosis

60 Degrees Pharmaceuticals’ Tafenoquine Gains the US FDA’s Orphan Drug Designation to Treat Acute Babesiosis

  • June 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.